ROSETTE-FORMING GLIONEURONAL TUMOR

Clinical trials for ROSETTE-FORMING GLIONEURONAL TUMOR explained in plain language.

Never miss a new study

Get alerted when new ROSETTE-FORMING GLIONEURONAL TUMOR trials appear

Sign up with your email to follow new studies for ROSETTE-FORMING GLIONEURONAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tracking Kids' health years after brain tumor treatment

Disease control Ongoing

This study follows children and teens who are already taking the medications dabrafenib and/or trametinib for various types of brain tumors. The main goal is to monitor their long-term health, safety, and development while they continue treatment. Researchers will track side effe…

Matched conditions: ROSETTE-FORMING GLIONEURONAL TUMOR

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

ROSETTE-FORMING GLIONEURONAL TUMOR

Get alerted when new ROSETTE-FORMING GLIONEURONAL TUMOR trials appear

Tracking Kids' health years after brain tumor treatment